Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $RNTX
Rein Therapeutics Inc.
Subscribe to $RNTX
$RNTX
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2017
Exchange: NASDAQ
Recent Analyst Ratings for Rein Therapeutics Inc.
Date
Price Target
Rating
Analyst
1/28/2025
$8.00
Buy
Rodman & Renshaw
See more ratings
